Loading clinical trials...
Loading clinical trials...
Oxytocin to Reduce Stress-induced Craving in Individuals With Opioid Use Disorder
Conditions
Interventions
intranasal oxytocin, 40 IU, twice a day for 7 days
Locations
1
United States
Brown University
Providence, Rhode Island, United States
Start Date
January 6, 2020
Primary Completion Date
December 22, 2023
Completion Date
December 23, 2023
Last Updated
May 25, 2025
NCT06651177
NCT06843213
NCT05995886
NCT07044466
NCT07350148
NCT06585709
Lead Sponsor
Brown University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions